Medicare Enrolled

Dr. Kathryn Petrie

Nurse Practitioner - Family · Fitzgerald, GA
Low-engagement
118 NORMAN DORMINY DR, Fitzgerald, GA 31750
2294239561
In practice since 2014 (11 years)
NPI: 1619365632 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Petrie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Petrie? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Petrie

Dr. Kathryn Petrie is a nurse practitioner - family in Fitzgerald, GA, with 11 years of NPI registration.

Between the years covered by Open Payments, Dr. Petrie received a total of $2,210 from 25 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Petrie is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice $2,210 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,210
Total received (2021-2024)
Avg $553/year across 4 years
Top 15% in GA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
123
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,148 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$62 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$701
2023
$705
2022
$497
2021
$307

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$195
ABBVIE INC.
$144
AstraZeneca Pharmaceuticals LP
$115
Lilly USA, LLC
$63
Dexcom, Inc.
$47
Otsuka America Pharmaceutical, Inc.
$43
Novo Nordisk Inc
$25
Axsome Therapeutics, Inc.
$24
Sumitomo Pharma America, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$15
IBSA Pharma Inc.
$14
Top 3 companies account for 64.8% of 2024 payments
All-time payments by company (2021-2024) ›
GlaxoSmithKline, LLC.
$448
ABBVIE INC.
$379
Novo Nordisk Inc
$254
AstraZeneca Pharmaceuticals LP
$240
Astellas Pharma US Inc
$211
Lilly USA, LLC
$144
Axsome Therapeutics, Inc.
$56
Dexcom, Inc.
$47
Sunovion Pharmaceuticals Inc.
$46
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
IDORSIA PHARMACEUTICALS US INC
$45
Otsuka America Pharmaceutical, Inc.
$43
AbbVie Inc.
$42
SANOFI-AVENTIS U.S. LLC
$36
ITI, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$19
Gilead Sciences, Inc.
$17
Sumitomo Pharma America, Inc.
$17
Janssen Pharmaceuticals, Inc
$17
EISAI INC.
$15
Boston Scientific Corporation
$15
IBSA Pharma Inc.
$14
Corium, Inc.
$13
C. R. Bard, Inc. & Subsidiaries
$13
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 48.9% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · Auvelity · Azstarys · BREZTRI · CAPLYTA · CREON · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · FARXIGA · GEMTESA · JARDIANCE · Kerendia · LINZESS · MOUNJARO · MYRBETRIQ · Myrbetriq · Ozempic · PUREWICK · QUVIVIQ · REXULTI · Rybelsus · SOLIQUA 100/33 · TRELEGY ELLIPTA · Tirosint · UBRELVY · VIBERZI · VRAYLAR · Veklury · Veozah · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nurse practitioner - family in Fitzgerald?
Compare family nurse practitioners in the Fitzgerald area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
128
Per 100K population
746.9
County median income
$39,081
Nearest hospital
DORMINY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Petrie is a nurse practitioner - family, with low-engagement industry engagement in the top 15% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Petrie receive payments from pharmaceutical companies?
Yes. Dr. Petrie received a total of $2,210 from 25 companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Petrie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Fitzgerald
Browse family nurse practitioners in Fitzgerald ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in GA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in GA
Which GA family nurse practitioners receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →